ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Oxford University Press Wins CRADA For Journal Of The National Cancer Istitute

September 20, 1996

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

Fox Chase Publishes Its Cancer Survival Data

February 4, 2011

ASCO: NCI Authorities Still Important

June 11, 2010

In Brief: Preyer, Waxman Battle Over Chairmanship Of Health Group; Amos To Head Mas. ACS

January 12, 1979

Scientists Lose Credibility When “Fire Alarm” Pulled Too Early, ACS’s Brawley Says.

August 1, 2008